InvestSMART

Firebrick Pharma Limited (ASX: FRE) - Announcements

- Current share price for FRE : $0.028

ASX company news and announcements for Firebrick Pharma Limited (FRE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Firebrick Pharma Limited (FRE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Firebrick Pharma Limited (FRE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Firebrick Pharma Limited (FRE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9 March 2024 Quarterly Activity Report & Appendix 4C 23 Apr 2024 8:26AM $0.077 $0.028 fallen by 63.64%
$9 Nasodine Nasal Spray Launch in the USA 17 Apr 2024 8:31AM $0.051 $0.028 fallen by 45.10%
$9 Nasodine Phase 2 COVID-19 Trial Results Published 2 Apr 2024 9:50AM $0.050 $0.028 fallen by 44%
$9 Becoming a substantial holder 28 Mar 2024 6:51PM $0.050 $0.028 fallen by 44%
$9 Nasodine COVID-19 Patent Allowed in US 4 Mar 2024 9:20AM $0.051 $0.028 fallen by 45.10%
$9 Appendix 4D & Half-Year Financial Report to 31 December 2023 28 Feb 2024 7:11PM $0.050 $0.028 fallen by 44%
$9 Application for quotation of securities - FRE 29 Jan 2024 1:35PM $0.054 $0.028 fallen by 48.15%
$9 Cleansing Notice 24 Jan 2024 8:36AM $0.055 $0.028 fallen by 49.09%
$9 Application for quotation of securities - FRE 24 Jan 2024 8:35AM $0.055 $0.028 fallen by 49.09%
$9 December 2023 Quarterly Activity Report & Appendix 4C 23 Jan 2024 4:33PM $0.055 $0.028 fallen by 49.09%
$9 Release of Securities from Escrow 12 Jan 2024 10:14AM $0.051 $0.028 fallen by 45.10%
$9 Firebrick Closes AAT Appeal 27 Dec 2023 8:30AM $0.052 $0.028 fallen by 46.15%
$9 Cleansing Notice 19 Dec 2023 12:08PM $0.050 $0.028 fallen by 44%
$9 Application for quotation of securities - FRE 19 Dec 2023 12:08PM $0.050 $0.028 fallen by 44%
$9 Nasodine COVID-19 Patent Granted in South Africa 29 Nov 2023 8:39AM $0.058 $0.028 fallen by 51.72%
$9 Results of Annual General Meeting 17 Nov 2023 3:26PM $0.078 $0.028 fallen by 64.10%
$9 Firebrick Investor Update 15 Nov 2023 8:47AM $0.037 $0.028 fallen by 24.32%
$9 Firebrick Receives $1.81m R&D Tax Incentive 31 Oct 2023 9:06AM $0.037 $0.028 fallen by 24.32%
$9 September 2023 Quarterly Activity Report & Appendix 4C 27 Oct 2023 8:49AM $0.038 $0.028 fallen by 26.32%
$9 Letter to Shareholders & Notice of AGM & Proxy Form 17 Oct 2023 8:24AM $0.040 $0.028 fallen by 30%
$9 Update on Nasodine Trial and Forward Plans 3 Oct 2023 9:11AM $0.050 $0.028 fallen by 44%
$9 Notice of AGM and Closing Date for Director Nominations 18 Sep 2023 11:45AM $0.062 $0.028 fallen by 54.47%
$9 Phase 3 Common Cold Trial Results 13 Sep 2023 9:42AM $0.330 $0.028 fallen by 91.52%
$9 Trading Halt 11 Sep 2023 9:37AM $0.330 $0.028 fallen by 91.52%
$9 Appendix 4G 29 Aug 2023 5:48PM $0.285 $0.028 fallen by 90.18%

201 - 225 of 523 results

Page 9 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.